Marsh McLennan (MRSH) and Willis Towers Watson (WTW) operate in the same space of global risk advisory, insurance brokerage, and benefits consulting. Yet their profiles have moved in different directions lately. I see this as a useful comparison for investors looking at defensive compounders or traders focused on relative momentum in financial services. Looking at business models, recent results, growth drivers, and sentiment side by side helps clarify which name might offer a better risk-adjusted profile right now. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Marsh McLennan runs a broad professional-services platform through risk and insurance services (Marsh and Guy Carpenter) plus consulting (Mercer and Oliver Wyman). Its market capitalization sits near $100 billion, making it the largest publicly traded insurance broker. In the latest quarter, MRSH posted revenue of roughly $6.86 billion, up 8% year over year (5% underlying), while adjusted EPS rose 10%. The shares have outpaced the broader market over the past 52 weeks and climbed about 30% in the last six months, underscoring a track record of earnings consistency. From what I see, recent activity has been helped by management raising its Thrive cost-savings target and an active acquisition pipeline that includes the planned purchase of Wilshire. Analyst views remain mostly positive with a Moderate Buy consensus, though a few firms have trimmed targets amid valuation concerns and softer commercial pricing. Insider selling has been light but noticeable.
Willis Towers Watson focuses on advisory, broking, and solutions across Health, Wealth & Career (HWC) and Risk & Broking (R&B). Its most recent quarter showed about 4% organic revenue growth, a 150-basis-point expansion in adjusted operating margin to 21.9%, and 18% growth in adjusted diluted EPS. Market capitalization is near $31 billion, with the stock moving in a 52-week range of roughly $240 to $351. I’m watching this closely because sentiment centers on the Propel AI Acceleration Plan, which aims for around $400 million in run-rate savings and a 30% adjusted operating margin by 2028. Growth in Health and Career has stood out, and the Willis Re joint venture continues to progress. That said, management slightly lowered its full-year organic-growth outlook due to delayed implementations, softer pricing, and mixed conditions in Insurance Consulting and Technology. The consensus remains Buy, with several recent target increases.
The main differences come down to scale and diversification versus focus and margin leverage. MRSH operates a large, four-business franchise with about $22 billion in trailing nine-month revenue and a long history of margin expansion, which gives it several growth levers but also a higher valuation. WTW is smaller and more concentrated, with its investment case tied closely to Propel success and margin recovery in a softer pricing environment. On momentum, MRSH has been steadier, holding near 52-week highs with four straight EPS beats. WTW has posted stronger percentage EPS growth but faces more near-term uncertainty from tempered guidance and declining commercial rates. Risk profiles differ too: MRSH carries acquisition-related debt, while WTW bears execution risk on its multi-year AI transformation and recent deal integrations. Valuation-wise, WTW screens as more attractive relative to consensus targets, whereas MRSH trades at a premium for its consistency and scale.
After weighing trend consistency, stability, catalysts, and relative positioning, Tickeron’s AI currently leans toward MRSH over WTW. The reasoning rests on observable factors: MRSH has held a steadier upward trend near its 52-week high, delivered reliable earnings beats, and benefits from a diversified revenue base plus catalysts such as the expanded Thrive program and ongoing acquisitions. In contrast, WTW offers a stronger margin-expansion narrative but carries greater near-term uncertainty around organic growth. This is a probabilistic view of current conditions rather than a firm prediction, and the balance could change with new data.
In my own research, I often review Tickeron’s Trending AI Robots to see which automated strategies are performing well on names like these in the current environment. The page highlights bots with strong recent results across different styles and timeframes, giving a practical way to evaluate AI-driven approaches without sifting through hundreds of options.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
I’m a trader and independent researcher. My interest lies at the intersection of financial markets, algorithms, and capital management. I develop data-driven tools and strategies and study algorithmic approaches to market analysis. I help turn complex market data into clear insights and practical systems. I believe technology should support, not replace, investment thinking
The 10-day moving average for WTW crossed bullishly above the 50-day moving average on October 26, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 77%.
WTW moved above its 50-day moving average on October 20, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +2.84% 3-day Advance, the price is estimated to grow further. Considering data from situations where WTW advanced for three days, in 145 of 307 cases, the price rose further within the following month. The odds of a continued upward trend are 47%.
The Aroon Indicator entered an Uptrend today. In 154 of 271 cases where WTW Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 57%.
The 10-day RSI Indicator for WTW moved out of overbought territory on November 06, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 34 similar instances where the indicator moved out of overbought territory. In 17 of the 34 cases, the stock moved lower in the following days. This puts the odds of a move lower at 50%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 31 of 69 cases where WTW's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 45%.
The Momentum Indicator moved below the 0 level on November 18, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on WTW as a result. In 50 of 104 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 48%.
The Moving Average Convergence Divergence Histogram (MACD) for WTW turned negative on November 17, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In 19 of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at 40%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where WTW declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 49%.
WTW broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron PE Growth Rating for this company is 14 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 43 (best 1 - 100 worst), indicating steady price growth. WTW’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 44 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 86, placing this stock slightly better than average.
The Tickeron SMR rating for this company is 47 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 81 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.973) is normal, around the industry mean (2.794). P/E Ratio (20.287) is within average values for comparable stocks, (19.877). Projected Growth (PEG Ratio) (1.265) is also within normal values, averaging (8.322). Dividend Yield (0.012) settles around the average of (0.042) among similar stocks. P/S Ratio (2.990) is also within normal values, averaging (3.106).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a provider of weight management services
Industry InsuranceBrokersServices